Synlab AG
XETRA:SYAB
Intrinsic Value
Synlab AG is a clinical laboratory and medical diagnostic services company. [ Read More ]
The intrinsic value of one SYAB stock under the Base Case scenario is 16.39 EUR. Compared to the current market price of 10.52 EUR, Synlab AG is Undervalued by 36%.
Valuation Backtest
Synlab AG
Run backtest to discover the historical profit from buying and selling SYAB stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Synlab AG
Current Assets | 789.1m |
Cash & Short-Term Investments | 265.6m |
Receivables | 397.6m |
Other Current Assets | 126m |
Non-Current Assets | 3.9B |
Long-Term Investments | 71.6m |
PP&E | 953.1m |
Intangibles | 2.8B |
Other Non-Current Assets | 51.5m |
Current Liabilities | 682.9m |
Accounts Payable | 289.7m |
Accrued Liabilities | 150.8m |
Other Current Liabilities | 242.3m |
Non-Current Liabilities | 1.6B |
Long-Term Debt | 1.4B |
Other Non-Current Liabilities | 235.9m |
Earnings Waterfall
Synlab AG
Revenue
|
2.6B
EUR
|
Cost of Revenue
|
-615.7m
EUR
|
Gross Profit
|
2B
EUR
|
Operating Expenses
|
-1.9B
EUR
|
Operating Income
|
104.7m
EUR
|
Other Expenses
|
-12.4m
EUR
|
Net Income
|
92.3m
EUR
|
Free Cash Flow Analysis
Synlab AG
SYAB Profitability Score
Profitability Due Diligence
Synlab AG's profitability score is 59/100. The higher the profitability score, the more profitable the company is.
Score
Synlab AG's profitability score is 59/100. The higher the profitability score, the more profitable the company is.
SYAB Solvency Score
Solvency Due Diligence
Synlab AG's solvency score is 34/100. The higher the solvency score, the more solvent the company is.
Score
Synlab AG's solvency score is 34/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
SYAB Price Targets Summary
Synlab AG
According to Wall Street analysts, the average 1-year price target for SYAB is 12.1 EUR with a low forecast of 8.79 EUR and a high forecast of 19.95 EUR.
Shareholder Return
SYAB Price
Synlab AG
Average Annual Return | -14.41% |
Standard Deviation of Annual Returns | 50.11% |
Max Drawdown | -72% |
Market Capitalization | 2.3B EUR |
Shares Outstanding | 219 775 222 |
Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Synlab AG is a clinical laboratory and medical diagnostic services company. The company is headquartered in Muenchen, Bayern and currently employs 27,337 full-time employees. The firm is engaged in laboratory services for human and veterinary medicine, as well as environmental analysis.
Contact
IPO
Employees
Officers
The intrinsic value of one SYAB stock under the Base Case scenario is 16.39 EUR.
Compared to the current market price of 10.52 EUR, Synlab AG is Undervalued by 36%.